↓ Skip to main content

S-Adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: A double-blind cross-over trial. [ISRCTN36233495]

Overview of attention for article published in BMC Musculoskeletal Disorders, February 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
10 tweeters
facebook
4 Facebook pages
wikipedia
5 Wikipedia pages
reddit
1 Redditor

Citations

dimensions_citation
99 Dimensions

Readers on

mendeley
83 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
S-Adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: A double-blind cross-over trial. [ISRCTN36233495]
Published in
BMC Musculoskeletal Disorders, February 2004
DOI 10.1186/1471-2474-5-6
Pubmed ID
Authors

Wadie I Najm, Sibylle Reinsch, Fred Hoehler, Jerome S Tobis, Phillip W Harvey

Abstract

S-adenosylmethionine (SAMe) is a dietary supplement used in the management of osteoarthritis (OA) symptoms. Studies evaluating SAMe in the management of OA have been limited to Non Steroidal Anti-inflammatory Drugs (NSAIDs) for comparison. The present study compares the effectiveness of SAMe to a cyclooxygenase-2 (COX-2) inhibitor (celecoxib) for pain control, functional improvement and to decrease side effects in people with osteoarthritis of the knee.

Twitter Demographics

The data shown below were collected from the profiles of 10 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Italy 1 1%
Unknown 81 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 19%
Student > Master 14 17%
Student > Bachelor 11 13%
Other 8 10%
Student > Ph. D. Student 6 7%
Other 13 16%
Unknown 15 18%
Readers by discipline Count As %
Medicine and Dentistry 26 31%
Agricultural and Biological Sciences 15 18%
Nursing and Health Professions 5 6%
Biochemistry, Genetics and Molecular Biology 4 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Other 11 13%
Unknown 18 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 September 2020.
All research outputs
#970,234
of 18,008,158 outputs
Outputs from BMC Musculoskeletal Disorders
#172
of 3,371 outputs
Outputs of similar age
#9,116
of 164,716 outputs
Outputs of similar age from BMC Musculoskeletal Disorders
#1
of 1 outputs
Altmetric has tracked 18,008,158 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,371 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 164,716 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them